Welcome to the Washington State Medical Oncology Society Website

The purpose of the Washington State Medical Oncology Society (WSMOS) is:

  • To promote the highest professional standards of oncology practice in the state of Washington.
  • To study, research and exchange information, experiences and ideals leading to improvement in the practice of oncology.
  • To represent the practice of oncology and hematology in the state of Washington.

Regularly Monitor the WSMOS Website for:

  • WSMOS meetings & events
  • Legislative updates
  • Billing & reimbursement updates
  • Resources & tools
  • Oncology news
  • Newsletter
  • Practice Pattern Changes Survey

July 21, 2018 MAC JF/JE Caucus Presentations:

340B - Jeffery C. Ward

Johnson & Johnson 2017 Transparency Report and Response to Blueprint - Michael Barnard - Director, Federal Affairs

Are Drug Prices Too High? If so, Why? - Geoffey Joyce, PhD, University of Southern California

Drug Prices & Patient Costs - Veena Shankaran, MD, MS, HICOR, Fred Hutchinson Cancer Research Center and University of Washington

Medicare Update - Dick Whitten, MD, FACP, Contractor Medical Director, Noridian

Diamond Partners See All

  • Abbvie
  • Alexion
  • Amgen
  • Astellas Pharma US
  • Bayer Healthcare
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Coherus BioSciences
  • Eisai, Inc.
  • Genetech BioOncology
  • Genomic Health
  • Heron Therapeutics
  • Lilly Oncology
  • Merck
  • Pfizer Oncology
  • Sandoz Oncology
  • Taiho Oncology
  • Takeda
  • Teva Oncology